Michael P. Dube - 05 Jan 2026 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: VP, Chief Accounting Officer
Signature: James Basta, attorney-in-fact
Issuer symbol: NTLA
Transactions as of: 05 Jan 2026
Net transactions value: -$27,529
Form type: 4
Filing time: 07 Jan 2026, 16:01:51 UTC
Previous filing: 03 Oct 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dube Michael P	VP, Chief Accounting Officer	C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE	James Basta, attorney-in-fact	07 Jan 2026	0002019493

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTLA	Common Stock	Sale	$27,529	-2,989	-5.4%	$9.21	52,277	05 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.